Advertisement
Screener

FALCON POINT CAPITAL, LLC Historic Quarter Change: USA ETF, Added

FALCON POINT CAPITAL, LLC historic quarter change: USA ETF, Added

In exchange-traded fund shares (known by the fund name on the filing) (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, FALCON POINT CAPITAL, LLC opened 7 positions, added to 7, reduced 2 and sold out of 3.

  • Q3 2016: Stock XBI; Country of operation —; Class COM; Shares before 22,852.
  • Q2 2016: Stock XBI; Country of operation —; Class COM; Shares before 20,300.
  • Q1 2016: Stock XBI; Country of operation —; Class COM; Shares before 18,032.
  • Q4 2015: Stock XBI; Country of operation —; Class COM; Shares before 16,815.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1251557), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-08); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-07-26); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-15); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-20); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-03); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-13); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-26); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-29); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-30); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-28); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-28); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-01). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2003-06-30.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2016XBI
SPDR S&P 500 Biotech
COM22,85225,081+2,229$1,236,000$1,408,000+$172,0002016-11-08
Q2 2016XBI
SPDR S&P 500 Biotech
COM20,30022,852+2,552$1,049,000$1,236,000+$187,0002016-07-26
Q1 2016XBI
SPDR S&P 500 Biotech
COM18,03220,300+2,268$1,266,000$1,049,000-$217,0002016-04-15
Q4 2015XBI
SPDR S&P 500 Biotech
COM16,81518,032+1,217$1,047,000$1,266,000+$219,0002016-02-16
Q3 2015XBI
SPDR S&P 500 Biotech
COM6,85516,815+9,960$1,729,000$1,047,000-$682,0002015-10-20
Q1 2015XBI
SPDR S&P 500 Biotech
COM6,8256,879+54$1,273,000$1,551,000+$278,0002015-04-13
Q4 2014XBI
SPDR S&P 500 Biotech
COM5,7616,825+1,064$899,000$1,273,000+$374,0002015-01-26

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet